6 Passive exposure to cigarette smoke, other types of tobacco smoke (e.g., pipe, cigar, water pipe), 7–9 and marijuana 10 are also risk factors for COPD. Cigarette smokers have a higher prevalence of respiratory symptoms and lung function abnormalities, a greater annual rate FEV 1 decline and a greater COPD mortality rate than non-smokers 5 yet fewer than 50% of heavy smokers develop COPD. 4 Environmental Risk FactorsĬigarette smoking is a key environmental risk factor for COPD. Pathogenesis: Causes and Risk FactorsĬOPD results from dynamic, cumulative and repeated gene (G) – environment (E) interactions over the lifetime (T) that damage the lungs and/or alter their normal development/aging processes ( GETomics). GOLD 2023 defines COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, expectoration and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. 2 Accordingly, GOLD 2023 proposes a new definition of COPD that, at variance with previous documents, 3 focuses exclusively on these characteristics, separately from its epidemiology, causes, risk factors and diagnostic criteria that are discussed on their own. The definition of a disease should only include the characteristics that distinguishes it from other diseases. 1 Here, we present an executive summary of this GOLD 2023 report 1 that summarizes aspects that (a) are relevant from a clinician's perspective and (b) updates evidence published since the prior executive summary in 2017. 1 It contains important changes compared to earlier versions, and incorporates 387 new references. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published the complete 2023 GOLD report, which can be freely downloaded from its web page ( together with a “pocket guide” and “teaching slide set”. Comorbidities, multimorbidity and frailty. Hospital discharge, early readmissions, and follow-up.Surgical and endoscopic lung volume reduction.Choice and appropriate use of inhaler devices.Combined initial copd assessment: from abcd to abe.Lung function trajectories: lung development and ageing.The Journal expresses the voice of the Spanish Respiratory Society of Pulmonology and Thoracic Surgery (SEPAR) as well as that of other scientific societies such as the Latin American Thoracic Society (ALAT) and the Iberian American Association of Thoracic Surgery (AICT).Īuthors are also welcome to submit their articles to the Journal's open access companion title, Open Respiratory Archives. Furthermore, the Journal is also present in Twitter and Facebook. Manuscripts will be submitted electronically using the following web site:, link which is also accessible through the main web page of Archivos de Bronconeumologia.Īccess to any published article, is possible through the Journal's web page as well as from PubMed, Science Direct, and other international databases. The Journal is published monthly in English. It is a monthly Journal that publishes a total of 12 issues and a few supplements, which contain articles belonging to the different sections.Īll the manuscripts received in the Journal are evaluated by the Editors and sent to expert peer-review while handled by the Editor and/or an Associate Editor from the team. Other types of articles such as reviews, editorials, a few special articles of interest to the society and the editorial board, scientific letters, letters to the Editor, and clinical images are also published in the Journal. Archivos de Bronconeumologia is a scientific journal that preferentially publishes prospective original research articles whose content is based upon results dealing with several aspects of respiratory diseases such as epidemiology, pathophysiology, clinics, surgery, and basic investigation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |